Sexual Dysfunction Very Common in CKD Patients
MUNICH, GERMANY—Sexual dysfunction is highly prevalent in men and women with CKD, data show.
Diagnosis & Disease Information
CKD-Related Anemia Occurs Earlier in Women than Men
MUNICH, GERMANY—Among individuals with CKD, anemia occurs earlier in women than men, French researchers reported at the European Renal Association-European Dialysis and Transplant Association 2010 Congress.
Elevated FGF-23 Bad for CKD Patients
It predicts an increased risk of cardiovascular events and death in those not on dialysis.
Gout Drug Helps CKD Patients
Allopurinol, a drug used to treat gout, may slow progression of kidney disease in CKD patients, according to new findings scheduled to be published in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Widely Used Cancer Drug May Cause Renal Damage
Adding bevacizumab to cancer chemotherapy significantly increases the risk of high-grade proteinuria and nephrotic syndrome, according to a new report.
Microalbuminuria Found to Increase Risk of Chronic Kidney Disease
Increased levels of protein in urine may indicate a higher risk of developing kidney and cardiovascular problems among individuals with hypertension.
Teaching Dialysis Patients About Phosphorus
They need to know how to identify phosphate additives on food labels.
CKD Common in People with Undiagnosed Diabetes
Individuals with undiagnosed diabetes or prediabetes have a relatively high prevalence of CKD, according to a new study.
Better Preparation Before Dialysis Improves Survival
Patients with renal disease who are well prepared to start dialysis are significantly more likely to survive their first year of treatment, according to a study presented at the National Kidney Foundation’s 2010 Spring Clinical Meetings.
Repeat Injections of Ferumoxytol Well Tolerated
Ferumoxytol, a novel IV iron replacement therapy for CKD patients with iron deficiency anemia, is well tolerated regardless of the number of injections or interval between injections.
- Loading...
Loading...
Loading... 
Loading...